Skip to main content
Clinical Trials/ITMCTR2000003021
ITMCTR2000003021
Not yet recruiting
未知

Traditional Chinese medicine cooperative therapy for patients with Bladder Cancer after operation: a randomized controlled trial

Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine0 sitesTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional study
Sex
Male

Investigators

Sponsor
Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine

Eligibility Criteria

Inclusion Criteria

  • 1\. In line with transurethral resection of bladder tumor (TURPBT), and pathological diagnosis of malignant tumors;
  • 2\. The Karnofsky Performance Status (KPS) score \>60 points, and the expected survival period \>1 year;
  • 3\. Aged 25 to 80 years;
  • 4\. Those who have voluntarily signed an informed consent form.

Exclusion Criteria

  • 1\. Allergic constitution and those who are allergic to experimental drugs;
  • 2\. Patients with renal cancer, bladder tuberculosis, and urinary calculi;
  • 3\. Combined with other malignant tumor patients;
  • 4\. Patients with blood system diseases, coagulopathy and autoimmune diseases;
  • 5\. Combined with severe cardiovascular disease, cerebrovascular disease, hematopoietic system disease, neuropathic patients;
  • 6\. Participated in other clinical researchers 3 months before the trial;
  • 7\. Non\-resection of bladder tumors.

Outcomes

Primary Outcomes

Not specified

Similar Trials